RP
Rahul Purwar
About Rahul Purwar
Data last updated:
Rahul Purwar is a Director at Advy Biosciences Private Limited (since 2022), Director at Immunoadoptive Cell Therapy Private Limited (since 2018) and Director at Immunoact Research Foundation (since 2023). The companies operate in Chemicals and Materials, Healthcare and Software. The 3 current companies with reported revenue have a combined latest revenue of ₹272 Cr; the largest is Advy Biosciences Private Limited at ₹195 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Advy Biosciences Private Limited U24297MH2010PTC209352 | Director | 24 Jun 2022 | 2010 | ₹195 Cr (FY 2025) | Active |
 Immunoadoptive Cell Therapy Private Limited U74999MH2018PTC315497 | Director | 08 Oct 2018 | 2018 | ₹77.75 Cr (FY 2026) | Active |
| Immunoact Research Foundation U72200MH2023NPL413615 | Director | 09 Nov 2023 | 2023 | ₹3.6 Lakh (FY 2025) | Active |
Board colleagues of Rahul Purwar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ajeet Singh Karan | 00183622 | Advy Biosciences Private Limited | Director |
| Raj Nautam Parekh | 02681991 | Advy Biosciences Private Limited | Director |
| Siddharth Bharat Daftary | 02897197 | Advy Biosciences Private Limited | Managing Director |
| Atharva Ajay Karulkar | 09381466 | Immunoadoptive Cell Therapy Private Limited | Director |
| Ravindranath Kancherla | 00117940 | Immunoadoptive Cell Therapy Private Limited | Nominee Director |
| Satyanarayana Chava | 00211921 | Immunoadoptive Cell Therapy Private Limited | Nominee Director |
| Shalini Rahul Purwar | 08251943 | Immunoadoptive Cell Therapy Private Limited , Immunoact Research Foundation | Whole-Time Director |
| Shirish Arya | 05356174 | Immunoadoptive Cell Therapy Private Limited , Immunoact Research Foundation | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rahul Purwar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rahul Purwar
Rahul Purwar currently holds 3 directorships: Advy Biosciences Private Limited (Director, since 24 Jun 2022, revenue ₹195 Cr (FY 2025)); Immunoadoptive Cell Therapy Private Limited (Director, since 08 Oct 2018, revenue ₹77.75 Cr (FY 2026)); Immunoact Research Foundation (Director, since 09 Nov 2023, revenue ₹3.6 Lakh (FY 2025)).
Rahul Purwar was first appointed on 08 Oct 2018 as Director at Immunoadoptive Cell Therapy Private Limited. The most recent appointment on record is 09 Nov 2023 at Immunoact Research Foundation.
The 3 current companies of Rahul Purwar that report revenue have a combined latest revenue of ₹272 Cr: Advy Biosciences Private Limited ₹195 Cr (FY 2025); Immunoadoptive Cell Therapy Private Limited ₹77.75 Cr (FY 2026); Immunoact Research Foundation ₹3.6 Lakh (FY 2025).
The current boards of Rahul Purwar's companies include Ajeet Singh Karan (Advy Biosciences Private Limited), Raj Nautam Parekh (Advy Biosciences Private Limited), Siddharth Bharat Daftary (Advy Biosciences Private Limited), Atharva Ajay Karulkar (Immunoadoptive Cell Therapy Private Limited), Ravindranath Kancherla (Immunoadoptive Cell Therapy Private Limited), Satyanarayana Chava (Immunoadoptive Cell Therapy Private Limited), among others.